Literature DB >> 21522185

The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein.

Ken Op de Beeck1, Guy Van Camp, Sofie Thys, Nathalie Cools, Isabelle Callebaut, Karen Vrijens, Luc Van Nassauw, Viggo F I Van Tendeloo, Jean Pierre Timmermans, Lut Van Laer.   

Abstract

DFNA5 was first identified as a gene causing autosomal dominant hearing loss (HL). Different mutations have been found, all exerting a highly specific gain-of-function effect, in which skipping of exon 8 causes the HL. Later reports revealed the involvement of the gene in different types of cancer. Epigenetic silencing of DFNA5 in a large percentage of gastric, colorectal and breast tumors and p53-dependent transcriptional activity have been reported, concluding that DFNA5 acts as a tumor suppressor gene in different frequent types of cancer. Despite these data, the molecular function of DFNA5 has not been investigated properly. Previous transfection studies with mutant DFNA5 in yeast and in mammalian cells showed a toxic effect of the mutant protein, which was not seen after transfection of the wild-type protein. Here, we demonstrate that DFNA5 is composed of two domains, separated by a hinge region. The first region induces apoptosis when transfected in HEK293T cells, the second region masks and probably regulates this apoptosis inducing capability. Moreover, the involvement of DFNA5 in apoptosis-related pathways in a physiological setting was demonstrated through gene expression microarray analysis using Dfna5 knockout mice. In view of its important role in carcinogenesis, this finding is expected to lead to new insights on the role of apoptosis in many types of cancer. In addition, it provides a new line of evidence supporting an important role for apoptosis in monogenic and complex forms of HL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21522185      PMCID: PMC3179363          DOI: 10.1038/ejhg.2011.63

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  27 in total

1.  The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage.

Authors:  Yoshiko Masuda; Manabu Futamura; Hiroki Kamino; Yasuyuki Nakamura; Noriaki Kitamura; Shiho Ohnishi; Yuji Miyamoto; Hitoshi Ichikawa; Tsutomu Ohta; Misao Ohki; Tohru Kiyono; Hiroshi Egami; Hideo Baba; Hirofumi Arakawa
Journal:  J Hum Genet       Date:  2006-08-02       Impact factor: 3.172

2.  Mutations in the gene encoding pejvakin, a newly identified protein of the afferent auditory pathway, cause DFNB59 auditory neuropathy.

Authors:  Sedigheh Delmaghani; Francisco J del Castillo; Vincent Michel; Michel Leibovici; Asadollah Aghaie; Uri Ron; Lut Van Laer; Nir Ben-Tal; Guy Van Camp; Dominique Weil; Francina Langa; Mark Lathrop; Paul Avan; Christine Petit
Journal:  Nat Genet       Date:  2006-06-25       Impact factor: 38.330

3.  Members of a novel gene family, Gsdm, are expressed exclusively in the epithelium of the skin and gastrointestinal tract in a highly tissue-specific manner.

Authors:  Masaru Tamura; Shigekazu Tanaka; Tomoaki Fujii; Aya Aoki; Hiromitu Komiyama; Kiyoshi Ezawa; Kenta Sumiyama; Tomoko Sagai; Toshihiko Shiroishi
Journal:  Genomics       Date:  2007-03-12       Impact factor: 5.736

4.  Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer.

Authors:  Myoung Sook Kim; Cinthia Lebron; Jatin K Nagpal; Young Kwang Chae; Xiaofei Chang; Yiping Huang; Tony Chuang; Keishi Yamashita; Barry Trink; Edward A Ratovitski; Joseph A Califano; David Sidransky
Journal:  Biochem Biophys Res Commun       Date:  2008-03-17       Impact factor: 3.575

5.  Activation of cell death pathways in the inner ear of the aging CBA/J mouse.

Authors:  Su-Hua Sha; Fu-Quan Chen; Jochen Schacht
Journal:  Hear Res       Date:  2009-05-05       Impact factor: 3.208

6.  In CEM cells the autosomal deafness gene dfna5 is regulated by glucocorticoids and forskolin.

Authors:  M S Webb; A L Miller; E Brad Thompson
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

7.  Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma.

Authors:  M S Kim; X Chang; K Yamashita; J K Nagpal; J H Baek; G Wu; B Trink; E A Ratovitski; M Mori; D Sidransky
Journal:  Oncogene       Date:  2008-01-28       Impact factor: 9.867

8.  Evidence for a founder mutation causing DFNA5 hearing loss in East Asians.

Authors:  Hong-Joon Park; Hyun-Ju Cho; Jeong-In Baek; Tamar Ben-Yosef; Tae-Jun Kwon; Andrew J Griffith; Un-Kyung Kim
Journal:  J Hum Genet       Date:  2009-11-13       Impact factor: 3.172

9.  A novel DFNA5 mutation does not cause hearing loss in an Iranian family.

Authors:  Lut Van Laer; Nicole C Meyer; Mahdi Malekpour; Yasser Riazalhosseini; Mahdi Moghannibashi; Kimia Kahrizi; Ann Vandevelde; Fatemeh Alasti; Hossein Najmabadi; Guy Van Camp; Richard J H Smith
Journal:  J Hum Genet       Date:  2007-04-11       Impact factor: 3.172

10.  A novel DFNA5 mutation, IVS8+4 A>G, in the splice donor site of intron 8 causes late-onset non-syndromic hearing loss in a Chinese family.

Authors:  J Cheng; D Y Han; P Dai; H J Sun; R Tao; Q Sun; D Yan; W Qin; H Y Wang; X M Ouyang; S Z Yang; J Y Cao; G Y Feng; L L Du; Y Z Zhang; S Q Zhai; W Y Yang; X Z Liu; L He; H J Yuan
Journal:  Clin Genet       Date:  2007-09-14       Impact factor: 4.438

View more
  46 in total

1.  Conditional deletion of pejvakin in adult outer hair cells causes progressive hearing loss in mice.

Authors:  Suzan L Harris; Marcin Kazmierczak; Tina Pangršič; Prahar Shah; Nadiya Chuchvara; Alonso Barrantes-Freer; Tobias Moser; Martin Schwander
Journal:  Neuroscience       Date:  2017-01-09       Impact factor: 3.590

2.  Pejvakin-mediated pexophagy protects auditory hair cells against noise-induced damage.

Authors:  Jean Defourny; Alain Aghaie; Isabelle Perfettini; Paul Avan; Sedigheh Delmaghani; Christine Petit
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-01       Impact factor: 11.205

Review 3.  Inflammasomes: mechanism of assembly, regulation and signalling.

Authors:  Petr Broz; Vishva M Dixit
Journal:  Nat Rev Immunol       Date:  2016-06-13       Impact factor: 53.106

Review 4.  Gasdermin family: a promising therapeutic target for cancers and inflammation-driven diseases.

Authors:  Danbin Wu; Yefei Chen; Yingxin Sun; Qing Gao; Bin Yu; Xijuan Jiang; Maojuan Guo
Journal:  J Cell Commun Signal       Date:  2020-03-31       Impact factor: 5.782

5.  The expression and regulation of DFNA5 in human hepatocellular carcinoma DFNA5 in hepatocellular carcinoma.

Authors:  Cong-Jun Wang; Lin Tang; Dong-Wei Shen; Chao Wang; Qiong-Ying Yuan; Wei Gao; Yong-Kun Wang; Rong-Hua Xu; Hui Zhang
Journal:  Mol Biol Rep       Date:  2013-10-24       Impact factor: 2.316

Review 6.  Apoptosis in acquired and genetic hearing impairment: the programmed death of the hair cell.

Authors:  Ken Op de Beeck; Jochen Schacht; Guy Van Camp
Journal:  Hear Res       Date:  2011-07-18       Impact factor: 3.208

7.  An Integrated Bioinformatics and Computational Biology Approach Identifies New BH3-Only Protein Candidates.

Authors:  Robert G Hawley; Yuzhong Chen; Irene Riz; Chen Zeng
Journal:  Open Biol J       Date:  2012-05-04

8.  Pejvakin, a Candidate Stereociliary Rootlet Protein, Regulates Hair Cell Function in a Cell-Autonomous Manner.

Authors:  Marcin Kazmierczak; Piotr Kazmierczak; Anthony W Peng; Suzan L Harris; Prahar Shah; Jean-Luc Puel; Marc Lenoir; Santos J Franco; Martin Schwander
Journal:  J Neurosci       Date:  2017-02-16       Impact factor: 6.167

Review 9.  Mechanistic Insights into Gasdermin Pore Formation and Regulation in Pyroptosis.

Authors:  Chengliang Wang; Jianbin Ruan
Journal:  J Mol Biol       Date:  2021-10-08       Impact factor: 5.469

10.  Small fish, big prospects: using zebrafish to unravel the mechanisms of hereditary hearing loss.

Authors:  Barbara Vona; Julia Doll; Michaela A H Hofrichter; Thomas Haaf; Gaurav K Varshney
Journal:  Hear Res       Date:  2020-02-06       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.